Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Study on Extraction, Physicochemical Properties, and Bacterio-Static Activity of Polysaccharides from <i>Phellinus linteus</i>.

Molecules (Basel, Switzerland)·2023
Same author

A case of Pseudo-Lowering of Blood Routine Results caused by Improper Blood Collection Operation.

Clinical laboratory·2023
Same author

A Case of Pseudoelevation of Prostate Specific Antigen Level.

Clinical laboratory·2023
Same author

Renal interferon-inducible protein 16 expression is associated with disease activity and prognosis in lupus nephritis.

Arthritis research & therapy·2023
Same author

Chitosan-based hydrogel wound dressing: From mechanism to applications, a review.

International journal of biological macromolecules·2023
Same author

Chen's penetrating-suture technique for pancreaticojejunostomy following pancreaticoduodenectomy.

BMC surgery·2023

Related Experiment Video

Updated: Jun 27, 2026

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
07:52

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents

Published on: June 2, 2015

Deferroxamine preconditioning promotes long-lasting retinal ischemic tolerance.

Yanli Zhu1, Lihong Zhang, Jeffrey M Gidday

  • 1Department of Neurosurgery, Washington University School of Medicine, St. Louis, MO 63110, USA.

Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|December 3, 2008
PubMed
Summary

Deferroxamine (DFX) preconditioning protects the retina from ischemic injury. Multiple DFX doses induce long-lasting neuroprotection, suggesting a therapeutic potential for ischemic retinopathies.

More Related Videos

Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice
09:48

Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice

Published on: May 4, 2015

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
10:13

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Published on: July 31, 2017

Related Experiment Videos

Last Updated: Jun 27, 2026

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
07:52

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents

Published on: June 2, 2015

Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice
09:48

Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice

Published on: May 4, 2015

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
10:13

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Published on: July 31, 2017

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Pharmacology

Background:

  • Ischemic tolerance can be induced in the retina via preconditioning.
  • Pharmacological induction of ischemic tolerance is desirable for therapeutic applications.

Purpose of the Study:

  • To assess deferroxamine (DFX) for pharmacologically inducing retinal ischemic tolerance.
  • To investigate the role of hypoxia-inducible factor 1-alpha (HIF-1alpha) in DFX-induced neuroprotection.

Main Methods:

  • Mice were preconditioned with single or repetitive doses of DFX.
  • Retinal ischemia was induced 1 or 4 weeks post-preconditioning.
  • HIF-1alpha and adrenomedullin (ADM) expression were analyzed.

Main Results:

  • DFX preconditioning significantly attenuated ischemia-induced injury.
  • Repetitive DFX doses provided long-lasting neuroprotection.
  • DFX increased HIF-1alpha and ADM protein levels in the retina.

Conclusions:

  • DFX effectively preconditions the retina against ischemic injury.
  • DFX-induced preconditioning is HIF-1alpha-dependent, involving ADM.
  • DFX offers potential therapeutic utility for ischemic retinopathies.